• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

onychomycosis - Articles and news items

Moberg begins patient enrolment in US and Europe Phase 3 onychomycosis trials

Industry news / 28 September 2016 / Niamh Louise Marriott, Digital Content Producer

Approximately 10% of the general population suffer from onychomycosis and a majority of those afflicted go untreated. The prescription market is growing…


Webinar: NIR Spectroscopy for Assessing Blend Uniformity in the Pharmaceutical IndustryLEARN MORE
+ +